ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
WEDNESDAY, June 8, 2022 (HealthDay News) — An open-source automated insulin delivery (AID) system appears to be safe and effective for use in people with type 1 diabetes, according to a study presented at the annual meeting of the American Diabetes A…
Learn MoreConsuming Coffee May Lower Risk for Acute Kidney Injury
WEDNESDAY, June 8, 2022 (HealthDay News) — Higher coffee intake is associated with a lower risk for incident acute kidney injury (AKI), according to a study published online May 5 in Kidney International Reports.Kalie L. Tommerdahl, M.D., from the Un…
Learn MoreDual Decline in Memory, Gait Speed Tied to Higher Dementia Risk
WEDNESDAY, June 8, 2022 (HealthDay News) — The combination of decline in both gait speed and memory has the strongest association with dementia risk in older adults, according to a study published online May 31 in JAMA Network Open.Taya A. Collyer, P…
Learn MoreType 2 Diabetes Tied to Accelerated Brain Aging, Cognitive Decline
WEDNESDAY, June 8, 2022 (HealthDay News) — Type 2 diabetes mellitus (T2DM) is associated with neurocognitive changes suggestive of accelerated brain aging, according to a study published online May 24 in eLife.Botond Antal, from Stony Brook Universit…
Learn MoreADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
TUESDAY, June 7, 2022 (HealthDay News) — For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level, according to a study published online June 4 in the New England Journal of Medicine to coincide w…
Learn MoreBidirectional Risk Seen for Inflammatory Bowel Disease, Depression
TUESDAY, June 7, 2022 (HealthDay News) — There is a bidirectional association between inflammatory bowel disease (IBD) and depression, according to a study recently published in the Journal of Gastroenterology and Hepatology.Bing Zhang, M.D., from th…
Learn MoreASCO: Black Patients With Metastatic Breast Cancer Willing to Consider Clinical Trials
TUESDAY, June 7, 2022 (HealthDay News) — Black patients with metastatic breast cancer (MBC) are willing to consider participating in clinical trials, according to a study presented at the annual meeting of the American Society of Clinical Oncology, h…
Learn MoreFDA Panel to Decide on Novavax COVID-19 Vaccine
TUESDAY, June 7, 2022 (HealthDay News) — A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of the Novavax COVID-19 vaccine on Tuesday.The decision will be based on clinical trial data the com…
Learn MoreADA: Once-Weekly Tirzepatide Yields Lasting Weight Loss in Obesity
TUESDAY, June 7, 2022 (HealthDay News) — For individuals with obesity, tirzepatide is associated with lasting weight loss, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual meeting of the …
Learn MoreASCO: Desmoplastic Melanoma Responds to Neoadjuvant Pembrolizumab
TUESDAY, June 7, 2022 (HealthDay News) — For patients with resectable desmoplastic melanoma (DM), pembrolizumab treatment prior to resection results in a high pathological complete response (pCR) rate, according to a study presented at the annual mee…
Learn More